Dialysis Concentrate Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| CAGR | 5.73 % |
| Fastest Growing Market | Asia-Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Dialysis Concentrate Market Analysis
The dialysis concentrate market is projected to grow with a CAGR of 5.73% during the forecast period (2022 - 2027).
Coronavirus disease 2019 (COVID-19) has impacted the care and results of dialysis patients worldwide. SARS-CoV-2 infection and mortality are more common among dialysis patients, and many have experienced psychological anguish and delayed or poor care. According to an article published by the National Center for Biotechnology Information in May 2022, titled "COVID-19 in Dialysis: Clinical Impact, Immune Response, Prevention and Treatment", 15% to 20% excess mortality rates have been observed in patients on dialysis in the United States, in early 2020. According to a research article published in July 2020 titled 'COVID-19 and the Kidneys: An Update' published in Frontiers in Medicine Journal, the study results indicate that patients with kidney disease could represent a risk factor in elderly patients for a more severe disease course. Furthermore, a research article published by Hemodialysis International Journal in November 2020, titled 'The Impact of COVID19 in Hemodialysis Patients: Experience in a Hospital Dialysis Unit', found that COVID-19 has shown a high incidence and mortality rate in hemodialysis patients. Thus, early preventive measures against COVID-19 could decrease the risk of spreading the disease in vulnerable patients.
The factors driving the growth of the dialysis concentrate market are the rising prevalence of kidney diseases such as end-stage renal disease (ESRD), acute kidney injury (AKI), shortage of organ donors, risks associated with transplants, technological advancements, and initiatives by the leading players to introduce advanced products and services. For instance, according to a research article published in September 2020, titled 'Association of Age With Risk of Kidney Failure in Adults With Stage IV Chronic Kidney Disease in Canada', the study results found that the incidence rate of stage IV chronic kidney disease increased with age. For those 75 years and older, the risk of death was much higher than that of kidney failure. The high burden of chronic kidney disease is expected to boost the market, increasing the demand for renal dialysis and further increasing the demand for dialysis concentrates in the coming years. According to the study published by PlosOne, in February 2022, titled "Prevalence of Chronic Kidney Disease Stages 3-5 in Low-and Middle-Income Countries in Asia: A Systematic Review and Metanalysis", it has been found that the prevalence of chronic kidney disease stages 3-5 in low-and middle-income countries was 11.2%. In addition, the prevalence rate for chronic kidney disease in east Asia was 12%, 8.6% in east Asia, 12% in south-east Asia, 13.1% in western Asia, and 13.5% in South Asia.
Moreover, the mortality rate associated with chronic kidney diseases is increasing. For instance, according to the Centers for Disease Control, 2021, it has been found that Mississippi had the highest mortality rate for chronic kidney disease, in 2020, in the United States.
However, the complications in dialysis treatment and reimbursement policy issues in growing countries could stifle the dialysis concentrate market's growth.
Dialysis Concentrate Market Trends
This section covers the major market trends shaping the Dialysis Concentrate Market according to our research experts:
Hemodialysis Segment Expects to Drive the Market Growth
The factors driving the growth of the hemodialysis segment are increasing incidences of hypertension and diabetes, which leads to kidney failure, a rising number of patients with kidney disease, and a shortage in the availability of kidneys for transplants.
The rising number of geriatric population suffering from kidney diseases will likely boost the demand for the hemodialysis segment over the forecast period. According to the statistics published by the Centers for Disease Control, in 2021, 38% of people aged 65 years or older are at high risk of developing chronic kidney disease, 12% in people 45-64 years of age, and 6% in people aged 18-44 years.
Additionally, various technological innovations, government initiatives, and the introduction of compact-sized machines that can be conveniently used for home-based treatments significantly boost the demand for the hemodialysis segment. For instance, in March 2022, in India, Safdarjung Hospital set up a new unit with two hemodiafiltrations (HDF) machines, which help patients better purify kidneys during dialysis. In December 2020, Medtronic launched a dialysis machine for neonatal and pediatrics in the United States. Similarly, in October 2020, the United States-based privately held medical device company, Diality, invested around USD 12.5 million in developing a portable hemodialysis system to address the unmet technology needs of the evolving dialysis industry. Thus, the high burden of kidney disease is increasing the demand for hemodialysis, thereby contributing to the market's growth.
North America is Expected to Have the Significant Market Share
The rising incidence of kidney diseases such as end-stage renal disorder (ESRD), chronic kidney disease, and acute kidney injury are expected to drive the demand for hemodialysis. According to the statistics published by the National Institute of Diabetes and Digestive and Kidney Diseases, in September 2021, about 786,000 people in the United States are living with an end-stage renal disorder (ESRD), with 71% of the people are on dialysis, and 29% with a kidney transplant. According to the same source, nearly 500,000 Americans are affected by polycystic kidney disease (PKD), an inherited kidney disorder. According to the United States Organ Procurement and Transplantation Network, in August 2021, 22,817 kidney transplants were completed in the United States. In addition, 90,201 people were on the waiting list for a kidney transplant in the United States as of August 2021.
The incidence of chronic kidney disease is more common in females than males. According to the statistics published by the Centers for Disease Control updates from July 2021, 15% of adults in the United States are expected to have chronic kidney disease. In addition, slightly more common in women (14%) than men (12%).
Moreover, the research development initiatives and development of machines with advanced technology are also contributing to the growth of hemodialysis, further increasing the demand for dialysis concentrate in the region. For instance, in December 2020, Medtronic launched a dialysis machine for neonatal and pediatrics in the United States. Also, in January 2021, Quanta Dialysis Technologies Ltd, a British medical technology pioneer developing innovative dialysis products and services, received 510(k) clearance from the United States Food and Drug Administration to market its small and simple, high-performance hemodialysis system SC+ in the United States.
Thus, growing kidney disease cases and increasing development in the dialysis segment in the region are expected to boost the dialysis concentrates market growth in the coming years.
Dialysis Concentrate Industry Overview
The dialysis concentrate market is fragmented and highly competitive, with many players. The companies are adopting various business strategies such as expanding collaborations, partnerships, and acquisitions to retain their market position. Some key players include Fresenius Medical care, Baxter International Inc., B. Braun Melsungen AG, Asahi Kasei Medical Co. Ltd, and Rockwell Medical.
Dialysis Concentrate Market Leaders
-
Fresenius Medical Care
-
Baxter International Inc.
-
B. Braun Melsungen AG
-
Rockwell Medical
-
Nipro Renal Solutions
*Disclaimer: Major Players sorted in no particular order
Dialysis Concentrate Market News
- In April 2022, Rockwell Medical, Inc. announced an expanded partnership with DaVita Inc. to revise certain terms of its supply contracts with customers to stabilize its concentrates business.
- In March 2022, Nipro Medical Corporation, a manufacturer and supplier of renal, vascular, and medical-surgical products, launched the SURDIAL DX Hemodialysis System in the United States.
Dialysis Concentrate Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Increasing Prevalence of Kidney Diseases and Acute Kidney Injury
- 4.2.2 Increasing Investment in Research and Development
-
4.3 Market Restraints
- 4.3.1 Growing Concerns Regarding Reimbursement Policy and Treatment Complications
-
4.4 Porter's Five Forces Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD million)
-
5.1 By Type
- 5.1.1 Acid Concentrates
- 5.1.2 Bicarbonate Concentrates
- 5.1.3 Peritoneal Dialysis Fluid
-
5.2 By Application
- 5.2.1 Hemodialysis
- 5.2.2 Peritoneal Dialysis
-
5.3 By Dialysis Site
- 5.3.1 Hospital
- 5.3.2 Clinics & Dialysis Centers
- 5.3.3 Home Dialysis
-
5.4 Geography
- 5.4.1 North America
- 5.4.1.1 United States
- 5.4.1.2 Canada
- 5.4.1.3 Mexico
- 5.4.2 Europe
- 5.4.2.1 Germany
- 5.4.2.2 United Kingdom
- 5.4.2.3 France
- 5.4.2.4 Italy
- 5.4.2.5 Spain
- 5.4.2.6 Rest of Europe
- 5.4.3 Asia-Pacific
- 5.4.3.1 China
- 5.4.3.2 Japan
- 5.4.3.3 India
- 5.4.3.4 Australia
- 5.4.3.5 South Korea
- 5.4.3.6 Rest of Asia-Pacific
- 5.4.4 Middle-East and Africa
- 5.4.4.1 GCC
- 5.4.4.2 South Africa
- 5.4.4.3 Rest of Middle-East and Africa
- 5.4.5 South America
- 5.4.5.1 Brazil
- 5.4.5.2 Argentina
- 5.4.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 Fresenius Medical Care
- 6.1.2 Baxter International Inc.
- 6.1.3 B. Braun Melsungen AG
- 6.1.4 Rockwell Medical
- 6.1.5 MEDIVATORS Inc.
- 6.1.6 Dialysis Medical Solutions
- 6.1.7 Farmasol
- 6.1.8 Hemoclean
- 6.1.9 Nipro Renal Solutions
- 6.1.10 Browndove Healthcare Pvt Ltd
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityDialysis Concentrate Industry Segmentation
As per the scope of the report, dialysis concentrate comprises purified water, glucose, and electrolytes and is used in hemodialysis, where the solution is created according to the requirement and aids in electrolyte regulation and the removal of metabolic waste products. The Global Dialysis Concentrate Market is segmented by Type (Acid Concentrates, Bicarbonate Concentrates, and Peritoneal Dialysis Fluid), Applications (Hemodialysis and Peritoneal Dialysis), Dialysis site (Hospital, Clinics & Dialysis Centers, and Home Dialysis) and Geography (North America, Europe, Asia-Pacific, Middle East, and Africa, South America). The market report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (USD million) for the above segments.
| By Type | Acid Concentrates | |
| Bicarbonate Concentrates | ||
| Peritoneal Dialysis Fluid | ||
| By Application | Hemodialysis | |
| Peritoneal Dialysis | ||
| By Dialysis Site | Hospital | |
| Clinics & Dialysis Centers | ||
| Home Dialysis | ||
| Geography | North America | United States |
| Canada | ||
| Mexico | ||
| Geography | Europe | Germany |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
| Geography | Asia-Pacific | China |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| Rest of Asia-Pacific | ||
| Geography | Middle-East and Africa | GCC |
| South Africa | ||
| Rest of Middle-East and Africa | ||
| Geography | South America | Brazil |
| Argentina | ||
| Rest of South America |
Dialysis Concentrate Market Research FAQs
What is the current Global Dialysis Concentrate Market size?
The Global Dialysis Concentrate Market is projected to register a CAGR of 5.73% during the forecast period (2024-2029)
Who are the key players in Global Dialysis Concentrate Market?
Fresenius Medical Care, Baxter International Inc., B. Braun Melsungen AG, Rockwell Medical and Nipro Renal Solutions are the major companies operating in the Global Dialysis Concentrate Market.
Which is the fastest growing region in Global Dialysis Concentrate Market?
Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Global Dialysis Concentrate Market?
In 2024, the North America accounts for the largest market share in Global Dialysis Concentrate Market.
What years does this Global Dialysis Concentrate Market cover?
The report covers the Global Dialysis Concentrate Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Dialysis Concentrate Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Global Dialysis Concentrate Industry Report
Statistics for the 2024 Global Dialysis Concentrate market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Global Dialysis Concentrate analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
